Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Semixia is referenced as a traditional medicine, specifically mentioned in the context of Mongolian and Chinese medicine. It appears to be a herbal or natural product used for therapeutic purposes, such as in the treatment of drug-induced liver injury and possibly other conditions. In one clinical context, it is listed alongside Astragalus (a well-known medicinal herb), suggesting that it may either be a proprietary name for an herbal formulation or a specific preparation containing Astragalus or similar ingredients. The precise mechanism of action is not detailed in available sources, but its use within traditional medicine implies immunomodulatory or hepatoprotective effects typical of such formulations[7]. There are no indications that Semixia is a conventional pharmaceutical drug with defined molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Semixia.